Jennison Associates LLC Solid Biosciences Inc. Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$7.19 - $32.37 $5.66 Million - $25.5 Million	-787,657 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$21.32 - $46.34 $16.8 Million - $36.5 Million	787,657 New	787,657 $21.1 Million
Q2 2018 Aug 02, 2018	SELL	$7.33 - $43.15 $1.29 Million - $7.62 Million	-176,630 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$7.19 - $33.17 $1.27 Million - $5.86 Million	176,630 New	176,630 $1.33 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $31.4M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.